About
Dear Colleague
Considerable progress has been made over recent years in our understanding of psoriasis at both fundamental basic science and clinical levels. Identification of immunopathological mechanisms that lead to the expression of disease and elucidation of cellular processes which control proliferation and differentiation are integral to the development of new therapies and therapeutic approaches specifically designed for psoriasis. Furthermore, significant progress has been made in understanding the genetic architecture of psoriasis which in turn highlight key biological pathways, some shared with other auto-immune diseases. Emerging evidence suggests that psoriasis is associated with risk of cardiovascular disease and other comorbidities. The true relationships between these conditions and determination of mechanisms will be important in the long-term management of psoriasis. Building on the success of our previous International Congresses held every three years since 1996, Psoriasis: from Gene to Clinic is designed to provide a forum for experts from around the world to present and discuss cutting edge issues. Delegates are anticipated to include clinicians, scientists and members of the biotechnology and pharmaceutical industries.
To reflect the areas of current scientific and clinical interests, the meeting will concentrate on specific plenary topics: genes and pathogenesis; inflammation and immunity, comorbidites and targeted therapeutics. Invited keynote lectures given by three leading international experts from the world of academia – Professor Stephen Holgate, Southampton, UK; Professor Jens Schroeder, Kiel, Germany and; Professor Jonathan Barker, London,UK. – will complement the formal sessions. There will be plenty of opportunity for free communications on any aspect of psoriasis, either as oral or poster presentations. Time will be available for informal discussions. The high quality of the meeting is again reflected in our choice of venue. The Queen Elizabeth II Conference Centre is uniquely situated in the shadow of Big Ben, Westminster Abbey and the London Eye. The welcome reception will take place at the conference centre and the Congress Banquet will be held at the magnificent Natural History Museum, a unique, historic venue in the heart of London.
December is an excellent time to visit London and we hope that you will be able to join us.
Jonathan N W N Barker Christopher E M Griffiths
St John’s Institute of Dermatology The Dermatology Centre
London, UK University of Manchester, UK
CO-ORGANISERS AND CO-CHAIRMEN SCIENTIFIC COMMITTEE
Jonathan Barker: London, UK
Christopher Griffiths: Manchester, UK
SCIENTIFIC COMMITTEE
Hervé Bachelez: Paris, France
James Elder: Ann Arbor, USA
Alexa Kimball: Boston, USA
James Krueger: New York, USA
Alan Menter: Dallas, USA
Frank Nestle: London, UK
Errol Prens: Rotterdam, The Netherlands
Jörg Prinz: Munich, Germany
Peter Van de Kerkhof: Nijmegen, The Netherlands
Congress Venue
The Queen Elizabeth II Conference Centre
Broad Sanctuary
Westminster
London
SW1P 3EE |
